IM CANNABIS CORP. news, videos and press releases
For more news please use our advanced search feature.
IM CANNABIS CORP. - More news...
IM CANNABIS CORP. - More news...
- CSE Bulletin: Consolidation - IM Cannabis Corp. (IMCC)
- IM Cannabis announces Focus Medical's Import of 400 Kilograms of Premium-Indoor-Grown Dried Cannabis from Canada to Israel
- IM Cannabis Corp. Appoints Rinat Efrima as New Chief Executive Officer of IMC Holdings, the Company’s Israeli Subsidiary
- IM Cannabis to Launch WAGNERS Brand in Germany
- IM Cannabis to Acquire Oranim, Jerusalem's Leading Medical Cannabis Pharmacy
- IM Cannabis Announces Focus Medical's Receipt of Israeli Ministry of Health Import Permit; Plans to Launch WAGNERS Brand in Israel
- IM Cannabis Announces Fourth Installment of Shares in Connection with the Panaxia Transaction
- IM Cannabis Announces Third Quarter 2021 Financial Results and Provides Outlook and Business Update
- IMC Announces Third Installment of Shares in Connection with the Panaxia Transaction
- IMC Provides Further Details on Panaxia Transaction
- IM Cannabis Announces Q2 2021 Financial Results and Signing of Definitive Agreement to Acquire Vironna Pharm, Accelerating its Vertical Integration Strategy in Israel
- IMC Partners with Leading US Brand to Launch cbdMD Products in Israel and Provides Further Details on Panaxia Transaction
- IMC Announces Results of its Annual General and Special Meeting of Shareholders
- IMC Accelerates its Israeli Retail Position through Acquisition of Leading Retailer and Distributor Pharm Yarok and Rosen High Way
- IM Cannabis Provides Update on German Operations and Financial Outlook
- IM Cannabis Provides Business, Legal and Regulatory Update
- IM Cannabis Closes Acquisition of MYM Nutraceuticals
- MYM Shareholders Overwhelmingly Approve Plan of Arrangement with IM Cannabis
- IM Cannabis Proposed Acquisition of MYM Receives Positive Recommendations from Proxy Advisory Firms Glass Lewis and ISS
- IM Cannabis Clinical Survey Confirms Effectiveness of Proprietary Strains in Alleviating Symptoms of Seven Key Health Conditions
- IM Cannabis Announces Supply Agreement with Canadian LP The Flowr Corporation; Plan to Import Ultra-Premium Products as part of Enhanced Portfolio to Meet Growing Israeli Demand
- IMC Reports First Closing of the Panaxia Acquisition and Provides Update on Canadian Business Activities
- IM Cannabis Reports Record Q1 2021 Results
- IM Cannabis Announces Closing of US$ 35 Million Equity Financing
- IM Cannabis Announces Pricing of Proposed Public Offering of Securities
- IM Cannabis Announces Proposed Public Offering of Securities
- IM Cannabis Acquires Israel's Largest Retail and Online Pharmacy Business from Panaxia, Creating a Vertically Integrated Global Platform for the IMC Brand
- IM Cannabis Reports Fiscal 2020 Results; Provides Preliminary Q1 Results and Q2 Outlook
- Adjupharm Signs Supply Agreement with MediPharm Labs, Paving Way for IM Cannabis-Branded Extracts Launch in German Market
- IM Cannabis Provides Update on Adjupharm Business Developments in Germany
